Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Archives of Dermatology|January 19, 2005
Efficacy and safety observed during 24 weeks of efalizumab therapy in patients with moderate to severe plaque psoriasisAlan Menter, Kenneth Gordon, Wayne Carey, et al.
The Journal of Dermatological Treatment|August 19, 2016
Early clinical response to tofacitinib treatment as a predictor of subsequent efficacy: Results from two phase 3 studies of patients with moderate-to-severe plaque psoriasisHuaming Tan, Hernan Valdez, Chris E M Griffins, et al.
Chemical Communications (Cambridge, England)|August 6, 2024
FeS2 deposited on 3D-printed carbon microlattices as free-standing electrodes for lithium-ion batteriesCameron Romero, Zhi Liu, Kenneth Gordon, et al.
The New England Journal of Medicine|September 13, 2018
Phase 2 Trial of Selective Tyrosine Kinase 2 Inhibition in PsoriasisKim Papp, Kenneth Gordon, Diamant Thaçi, et al.
The Journal of Dermatological Treatment|October 25, 2012
Validation of the Psoriasis Symptom Inventory (PSI), a patient-reported outcome measure to assess psoriasis symptom severityDonald M Bushnell, Mona L Martin, Kelly McCarrier, et al.
ACS Applied Polymer Materials|April 24, 2026
Microstructure Control of Polymer Films via Air-Assisted Electrospray for Binderless ElectrodesKenneth Gordon, Nduka Ogbonna, Griffin Usie, et al.
Dermatology (Basel, Switzerland)|January 22, 2020
Characterization of Patients with Psoriasis in Challenging-to-Treat Body Areas in the Corrona Psoriasis RegistryKristina Callis Duffin, Marc A Mason, Kenneth Gordon, et al.
Journal of the American Academy of Dermatology|October 22, 2011
Integrated safety analysis: short- and long-term safety profiles of etanercept in patients with psoriasisDavid M Pariser, Craig L Leonardi, Kenneth Gordon, et al.
The Journal of Dermatological Treatment|July 4, 2019
Sustained and continuously improved efficacy of tildrakizumab in patients with moderate-to-severe plaque psoriasisBoni Elewski, Alan Menter, Jeffrey Crowley, et al.
JAMA Dermatology|May 26, 2018
Efficacy of Guselkumab Compared With Adalimumab and Placebo for Psoriasis in Specific Body Regions: A Secondary Analysis of 2 Randomized Clinical TrialsPeter Foley, Kenneth Gordon, Christopher E M Griffiths, et al.
Pageof 4